Discontinued — last reported Q1 '18

Current Assets

Allowance for Doubtful Accounts Receivable (Current)

Xylem Allowance for Doubtful Accounts Receivable (Current) decreased by 22.1% to $53.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $53.00M to $53.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 8.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ3 2015
Last reportedQ1 2018

How to read this metric

A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.

Detailed definition

This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...

Peer comparison

Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.

Metric ID: allowance_for_doubtful_accounts_receivable_current

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$41.00M$43.00M$44.00M$37.00M$41.00M$46.00M$50.00M$36.00M$45.00M$55.00M$56.00M$46.00M$54.00M$60.00M$59.00M$53.00M$61.00M$66.00M$68.00M$53.00M
QoQ Change+4.9%+2.3%-15.9%+10.8%+12.2%+8.7%-28.0%+25.0%+22.2%+1.8%-17.9%+17.4%+11.1%-1.7%-10.2%+15.1%+8.2%+3.0%-22.1%
YoY Change+0.0%+7.0%+13.6%-2.7%+9.8%+19.6%+12.0%+27.8%+20.0%+9.1%+5.4%+15.2%+13.0%+10.0%+15.3%+0.0%
Range$36.00M$68.00M
CAGR+5.6%
Avg YoY Growth+10.9%
Median YoY Growth+11.0%

Frequently Asked Questions

What is Xylem's allowance for doubtful accounts receivable (current)?
Xylem (XYL) reported allowance for doubtful accounts receivable (current) of $53.00M in Q1 2026.
How has Xylem's allowance for doubtful accounts receivable (current) changed year-over-year?
Xylem's allowance for doubtful accounts receivable (current) decreased by 0.0% year-over-year, from $53.00M to $53.00M.
What is the long-term trend for Xylem's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Xylem's allowance for doubtful accounts receivable (current) has grown at a 8.1% compound annual growth rate (CAGR), from $46.00M to $68.00M.
What does allowance for doubtful accounts receivable (current) mean?
The estimated portion of customer invoices that the company expects will never be paid.